BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leung DH, Narkewicz MR. Cystic Fibrosis-related cirrhosis. Journal of Cystic Fibrosis 2017;16:S50-61. [DOI: 10.1016/j.jcf.2017.07.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Valamparampil JJ, Gupte GL. Cystic fibrosis associated liver disease in children. World J Hepatol 2021; 13(11): 1727-1742 [PMID: 34904041 DOI: 10.4254/wjh.v13.i11.1727] [Reference Citation Analysis]
2 Li H, Lin L, Hu X, Li C, Zhang H. Liver Failure in a Chinese Cystic Fibrosis Child With Homozygous R553X Mutation. Front Pediatr 2019;7:36. [PMID: 30842938 DOI: 10.3389/fped.2019.00036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
3 Colomba J, Netedu SR, Lehoux-Dubois C, Coriati A, Boudreau V, Tremblay F, Cusi K, Rabasa-Lhoret R, Leey JA. Hepatic enzyme ALT as a marker of glucose abnormality in men with cystic fibrosis. PLoS One 2019;14:e0219855. [PMID: 31318914 DOI: 10.1371/journal.pone.0219855] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Yu H, Zhou A, Liu J, Tang Y, Yuan Q, Man Y, Xiang L. Management of systemic risk factors ahead of dental implant therapy: A beard well lathered is half shaved. J Leukoc Biol 2021;110:591-604. [PMID: 34231923 DOI: 10.1002/JLB.6MR0621-760RR] [Reference Citation Analysis]
5 Zarei K, Meyerholz DK, Stoltz DA. Early intrahepatic duct defects in a cystic fibrosis porcine model. Physiol Rep 2021;9:e14978. [PMID: 34288572 DOI: 10.14814/phy2.14978] [Reference Citation Analysis]
6 Freedman SD, Wilschanski M, Schwarzenberg SJ. Advancing the GI frontier for patients with CF. J Cyst Fibros 2018;17:1-2. [PMID: 29208346 DOI: 10.1016/j.jcf.2017.11.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Nalbantoglu I, Jain D. Cryptogenic cirrhosis: Old and new perspectives in the era of molecular and genomic medicine. Semin Diagn Pathol 2019;36:389-94. [PMID: 31395291 DOI: 10.1053/j.semdp.2019.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Yi SG, Lunsford KE, Bruce C, Ghobrial RM. Conquering combined thoracic organ and liver transplantation: indications and outcomes for heart-liver and lung–liver transplantation. Current Opinion in Organ Transplantation 2018;23:180-6. [DOI: 10.1097/mot.0000000000000509] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
9 Lahiri T, Sullivan JS. Recent advances in the early treatment of cystic fibrosis: Bridging the gap to highly effective modulator therapy. Pediatr Pulmonol 2021. [PMID: 34473419 DOI: 10.1002/ppul.25660] [Reference Citation Analysis]
10 Ekinci İB, Hızal M, Emiralioğlu N, Özçelik U, Yalçın E, Doğru D, Kiper N, Dayangaç-Erden D. Differentially expressed genes associated with disease severity in siblings with cystic fibrosis. Pediatr Pulmonol 2021;56:910-20. [PMID: 33369261 DOI: 10.1002/ppul.25237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 West NE, Flume PA. Unmet needs in cystic fibrosis: the next steps in improving outcomes. Expert Rev Respir Med 2018;12:585-93. [PMID: 29855230 DOI: 10.1080/17476348.2018.1483723] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
12 Squires JE, McKiernan P. Molecular Mechanisms in Pediatric Cholestasis. Gastroenterol Clin North Am. 2018;47:921-937. [PMID: 30337041 DOI: 10.1016/j.gtc.2018.07.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Dougherty PG, Wellmerling JH, Koley A, Lukowski JK, Hummon AB, Cormet-Boyaka E, Pei D. Cyclic Peptidyl Inhibitors against CAL/CFTR Interaction for Treatment of Cystic Fibrosis. J Med Chem 2020;63:15773-84. [PMID: 33314931 DOI: 10.1021/acs.jmedchem.0c01528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Sakiani S, Kleiner DE, Heller T, Koh C. Hepatic Manifestations of Cystic Fibrosis. Clin Liver Dis 2019;23:263-77. [PMID: 30947876 DOI: 10.1016/j.cld.2018.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
15 Kamal N, Surana P, Koh C. Liver disease in patients with cystic fibrosis. Curr Opin Gastroenterol 2018;34:146-51. [PMID: 29438119 DOI: 10.1097/MOG.0000000000000432] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
16 Al Qatarneh S, Michel HK, Lindblad D, Ozolek J, Venkat V, Weiner DJ. Pancreatic Cystosis and Intrahepatic Biliopathy in a Young Adult with Cystic Fibrosis. J Pediatr 2018;203:457-457.e1. [PMID: 30041939 DOI: 10.1016/j.jpeds.2018.05.054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Singh H, Coffey MJ, Ooi CY. Cystic Fibrosis-related Liver Disease is Associated With Increased Disease Burden and Endocrine Comorbidities. J Pediatr Gastroenterol Nutr 2020;70:796-800. [PMID: 32443033 DOI: 10.1097/MPG.0000000000002694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Brennan AL, Blackman SM. EnVisioning the future: Endocrinology in cystic fibrosis. J Cyst Fibros 2019;18:743-5. [PMID: 31680045 DOI: 10.1016/j.jcf.2019.09.012] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Lusman SS, Grand R. Approach to chronic abdominal pain in Cystic Fibrosis. J Cyst Fibros 2017;16 Suppl 2:S24-31. [PMID: 28986021 DOI: 10.1016/j.jcf.2017.06.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
20 Ratchford TL, Teckman JH, Patel DR. Gastrointestinal pathophysiology and nutrition in cystic fibrosis. Expert Review of Gastroenterology & Hepatology 2018;12:853-62. [DOI: 10.1080/17474124.2018.1502663] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
21 Konrad J, Eber E, Stadlbauer V. Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators. Paediatr Respir Rev 2020:S1526-0542(20)30181-0. [PMID: 33485777 DOI: 10.1016/j.prrv.2020.12.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]